DSGN
Price
$6.11
Change
+$0.10 (+1.66%)
Updated
Oct 3 closing price
Capitalization
342.54M
32 days until earnings call
INVA
Price
$17.48
Change
-$0.18 (-1.02%)
Updated
Oct 3 closing price
Capitalization
1.11B
25 days until earnings call
Interact to see
Advertisement

DSGN vs INVA

Header iconDSGN vs INVA Comparison
Open Charts DSGN vs INVABanner chart's image
Design Therapeutics
Price$6.11
Change+$0.10 (+1.66%)
Volume$81.6K
Capitalization342.54M
Innoviva
Price$17.48
Change-$0.18 (-1.02%)
Volume$1.07M
Capitalization1.11B
DSGN vs INVA Comparison Chart in %
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. INVA commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and INVA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 05, 2025
Stock price -- (DSGN: $6.11 vs. INVA: $17.48)
Brand notoriety: DSGN and INVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 48% vs. INVA: 138%
Market capitalization -- DSGN: $342.54M vs. INVA: $1.11B
DSGN [@Biotechnology] is valued at $342.54M. INVA’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileINVA’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • INVA’s FA Score: 1 green, 4 red.
According to our system of comparison, INVA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while INVA’s TA Score has 4 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 4 bearish.
  • INVA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than INVA.

Price Growth

DSGN (@Biotechnology) experienced а -7.00% price change this week, while INVA (@Biotechnology) price change was -7.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

DSGN is expected to report earnings on Nov 05, 2025.

INVA is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INVA($1.11B) has a higher market cap than DSGN($343M). INVA YTD gains are higher at: 0.749 vs. DSGN (-0.972). INVA has higher annual earnings (EBITDA): 112M vs. DSGN (-74.31M). INVA has more cash in the bank: 498M vs. DSGN (216M). DSGN has less debt than INVA: DSGN (1.95M) vs INVA (451M). INVA has higher revenues than DSGN: INVA (370M) vs DSGN (0).
DSGNINVADSGN / INVA
Capitalization343M1.11B31%
EBITDA-74.31M112M-66%
Gain YTD-0.9720.749-130%
P/E RatioN/A30.97-
Revenue0370M-
Total Cash216M498M43%
Total Debt1.95M451M0%
FUNDAMENTALS RATINGS
INVA: Fundamental Ratings
INVA
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
83
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNINVA
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 6 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PBSIX17.270.04
+0.23%
Polen US Small Company Growth Instl
MAIPX16.300.01
+0.06%
MAI Managed Volatility Institutional
FSCEX16.21N/A
N/A
Fidelity Advisor Small Cap C
JATIX79.36N/A
N/A
Janus Henderson Glb Tech and Innovt I
JEEFX16.86N/A
N/A
JHancock Infrastructure C

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+1.58%
IDYA - DSGN
52%
Loosely correlated
+1.62%
VRDN - DSGN
48%
Loosely correlated
+2.03%
DYN - DSGN
48%
Loosely correlated
+4.06%
SYRE - DSGN
47%
Loosely correlated
-0.56%
TRDA - DSGN
46%
Loosely correlated
+1.35%
More

INVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with DSGN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then DSGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
-0.99%
DSGN - INVA
34%
Loosely correlated
+1.58%
DTIL - INVA
34%
Loosely correlated
+0.37%
CLDX - INVA
33%
Loosely correlated
+2.17%
NRIX - INVA
33%
Poorly correlated
+3.30%
OCUL - INVA
32%
Poorly correlated
+3.16%
More